UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:ACSM2A-ABCC6 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: ACSM2A-ABCC6 | FusionPDB ID: 1525 | FusionGDB2.0 ID: 1525 | Hgene | Tgene | Gene symbol | ACSM2A | ABCC6 | Gene ID | 123876 | 368 |
Gene name | acyl-CoA synthetase medium chain family member 2A | ATP binding cassette subfamily C member 6 | |
Synonyms | A-923A4.1|ACSM2 | ABC34|ARA|EST349056|GACI2|MLP1|MOAT-E|MOATE|MRP6|PXE|PXE1|URG7 | |
Cytomap | 16p12.3 | 16p13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | acyl-coenzyme A synthetase ACSM2A, mitochondrialacyl-CoA synthetase medium-chain family member 2benzoate--CoA ligasebutyrate--CoA ligase 2Abutyryl-coenzyme A synthetase 2Amiddle-chain acyl-CoA synthetase 2A | multidrug resistance-associated protein 6URG7 proteinATP-binding cassette, sub-family C (CFTR/MRP), member 6anthracycline resistance-associated proteinmulti-specific organic anion transporter E | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | Q08AH3 | O95255 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000575558, ENST00000219054, ENST00000396104, ENST00000417235, ENST00000536134, ENST00000573854, ENST00000575690, ENST00000424070, | ENST00000205557, ENST00000574094, ENST00000575728, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 2 X 2 X 2=8 | 1 X 1 X 1=1 |
# samples | 2 | 1 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(1/1*10)=3.32192809488736 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ACSM2A [Title/Abstract] AND ABCC6 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ACSM2A(20492243)-ABCC6(16263710), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ACSM2A-ABCC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACSM2A-ABCC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACSM2A-ABCC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ACSM2A-ABCC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ACSM2A | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process | 19345228 |
Fusion gene breakpoints across ACSM2A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ABCC6 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | KIRC | TCGA-BP-4801-01A | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000417235 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4372 | 1442 | 2 | 3166 | 1054 |
ENST00000536134 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4464 | 1534 | 709 | 3258 | 849 |
ENST00000573854 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4553 | 1623 | 99 | 3347 | 1082 |
ENST00000219054 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4580 | 1650 | 135 | 3374 | 1079 |
ENST00000575690 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4909 | 1979 | 464 | 3703 | 1079 |
ENST00000396104 | ACSM2A | chr16 | 20492243 | + | ENST00000205557 | ABCC6 | chr16 | 16263710 | - | 4450 | 1520 | 5 | 3244 | 1079 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000417235 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.002385658 | 0.9976144 |
ENST00000536134 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.004238715 | 0.99576133 |
ENST00000573854 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.002695883 | 0.9973041 |
ENST00000219054 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.002889441 | 0.9971105 |
ENST00000575690 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.003414369 | 0.9965856 |
ENST00000396104 | ENST00000205557 | ACSM2A | chr16 | 20492243 | + | ABCC6 | chr16 | 16263710 | - | 0.002401659 | 0.99759835 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >1525_1525_1_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000219054_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=1079AA_BP=1 MNMHWLRKVQGLCTLWGTQMSSRTLYINSRQLVSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRLPSPALWWVNGKGKELMWNFRELSE NSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLR IKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILN ILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIR ESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRG IKDEDGYFQFMGRANDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVASFCR GYWLSLWADDPAVGGQQTQAALRGGIFGLLGCLQAIGLFASMAAVLLGGARASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKETDT VDVDIPDKLRSLLMYAFGLLEVSLVVAVATPLATVAILPLFLLYAGFQSLYVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFRTQA PFVAQNNARVDESQRISFPRLVADRWLAANVELLGNGLVFAAATCAVLSKAHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIVSVE RMQDYAWTPKEAPWRLPTCAAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIW IDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLAR -------------------------------------------------------------- >1525_1525_2_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000396104_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=1079AA_BP=1 MNMHWLRKVQGLCTLWGTQMSSRTLYINSRQLVSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRLPSPALWWVNGKGKELMWNFRELSE NSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLR IKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILN ILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIR ESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRG IKDEDGYFQFMGRANDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVASFCR GYWLSLWADDPAVGGQQTQAALRGGIFGLLGCLQAIGLFASMAAVLLGGARASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKETDT VDVDIPDKLRSLLMYAFGLLEVSLVVAVATPLATVAILPLFLLYAGFQSLYVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFRTQA PFVAQNNARVDESQRISFPRLVADRWLAANVELLGNGLVFAAATCAVLSKAHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIVSVE RMQDYAWTPKEAPWRLPTCAAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIW IDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLAR -------------------------------------------------------------- >1525_1525_3_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000417235_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=1054AA_BP=0 LSYCALFQGCRSSGAAGWRGGWTKLSLERHPERTWQAGKRLPSPALWWVNGKGKELMWNFRELSENSQQAANVLSGACGLQRGDRVAVVL PRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLRIKLLVSEKSCDGWLNFKKLLNEAST THHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDP LVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYM GTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRANDIINSSGYRI GPSEVENALMEHPAVVETAVISSPDPVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVASFCRGYWLSLWADDPAVGGQQTQAALRGG IFGLLGCLQAIGLFASMAAVLLGGARASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKETDTVDVDIPDKLRSLLMYAFGLLEVSLV VAVATPLATVAILPLFLLYAGFQSLYVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFRTQAPFVAQNNARVDESQRISFPRLVADR WLAANVELLGNGLVFAAATCAVLSKAHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIVSVERMQDYAWTPKEAPWRLPTCAAQPPW PQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIWIDGVPIAHVGLHTLRSRISIIPQDP ILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLARALLRKTQILILDEATAAVDPGTELQ -------------------------------------------------------------- >1525_1525_4_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000536134_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=849AA_BP=275 MRHPPLITVWRLEAKMDAGWTGLQASDIMWTISDTGWILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRML LQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEG DIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRGIKDEDGYFQFMGRANDIINSSGYRIGPSEVENALMEHPAVVETAVISSPD PVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVASFCRGYWLSLWADDPAVGGQQTQAALRGGIFGLLGCLQAIGLFASMAAVLLGGA RASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKETDTVDVDIPDKLRSLLMYAFGLLEVSLVVAVATPLATVAILPLFLLYAGFQSL YVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFRTQAPFVAQNNARVDESQRISFPRLVADRWLAANVELLGNGLVFAAATCAVLSK AHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIVSVERMQDYAWTPKEAPWRLPTCAAQPPWPQGGQIEFRDFGLRYRPELPLAVQG VSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIWIDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAA LETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLARALLRKTQILILDEATAAVDPGTELQMQAMLGSWFAQCTVLLIAHRLRSVM -------------------------------------------------------------- >1525_1525_5_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000573854_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=1082AA_BP=2 MAGLNMHWLRKVQGLCTLWGTQMSSRTLYINSRQLVSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRLPSPALWWVNGKGKELMWNFRE LSENSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECP SLRIKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGW ILNILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGL DIRESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLG DRGIKDEDGYFQFMGRANDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVAS FCRGYWLSLWADDPAVGGQQTQAALRGGIFGLLGCLQAIGLFASMAAVLLGGARASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKE TDTVDVDIPDKLRSLLMYAFGLLEVSLVVAVATPLATVAILPLFLLYAGFQSLYVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFR TQAPFVAQNNARVDESQRISFPRLVADRWLAANVELLGNGLVFAAATCAVLSKAHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIV SVERMQDYAWTPKEAPWRLPTCAAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEG GIWIDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLC LARALLRKTQILILDEATAAVDPGTELQMQAMLGSWFAQCTVLLIAHRLRSVMDCARVLVMDKGQVAESGSPAQLLAQKGLFYRLAQESG -------------------------------------------------------------- >1525_1525_6_ACSM2A-ABCC6_ACSM2A_chr16_20492243_ENST00000575690_ABCC6_chr16_16263710_ENST00000205557_length(amino acids)=1079AA_BP=1 MNMHWLRKVQGLCTLWGTQMSSRTLYINSRQLVSLQWGHQEVPAKFNFASDVLDHWADMEKAGKRLPSPALWWVNGKGKELMWNFRELSE NSQQAANVLSGACGLQRGDRVAVVLPRVPEWWLVILGCIRAGLIFMPGTIQMKSTDILYRLQMSKAKAIVAGDEVIQEVDTVASECPSLR IKLLVSEKSCDGWLNFKKLLNEASTTHHCVETGSQEASAIYFTSGTSGLPKMAEHSYSSLGLKAKMDAGWTGLQASDIMWTISDTGWILN ILCSLMEPWALGACTFVHLLPKFDPLVILKTLSSYPIKSMMGAPIVYRMLLQQDLSSYKFPHLQNCVTVGESLLPETLENWRAQTGLDIR ESYGQTETGLTCMVSKTMKIKPGYMGTAASCYDVQIIDDKGNVLPPGTEGDIGIRVKPIRPIGIFSGYVDNPDKTAANIRGDFWLLGDRG IKDEDGYFQFMGRANDIINSSGYRIGPSEVENALMEHPAVVETAVISSPDPVRGEVKATVHLAYLRAVGTPLCLYALFLFLCQQVASFCR GYWLSLWADDPAVGGQQTQAALRGGIFGLLGCLQAIGLFASMAAVLLGGARASRLLFQRLLWDVVRSPISFFERTPIGHLLNRFSKETDT VDVDIPDKLRSLLMYAFGLLEVSLVVAVATPLATVAILPLFLLYAGFQSLYVVSSCQLRRLESASYSSVCSHMAETFQGSTVVRAFRTQA PFVAQNNARVDESQRISFPRLVADRWLAANVELLGNGLVFAAATCAVLSKAHLSAGLVGFSVSAALQVTQTLQWVVRNWTDLENSIVSVE RMQDYAWTPKEAPWRLPTCAAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIW IDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLAR -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:20492243/chr16:16263710) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ACSM2A | ABCC6 |
FUNCTION: Catalyzes the activation of fatty acids by CoA to produce an acyl-CoA, the first step in fatty acid metabolism (By similarity). Capable of activating medium-chain fatty acids (e.g. butyric (C4) to decanoic (C10) acids), and certain carboxylate-containing xenobiotics, e.g. benzoate (By similarity). {ECO:0000250|UniProtKB:Q68CK6}. | FUNCTION: [Isoform 1]: ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS) (in vitro), and an anionic cyclopentapeptide endothelin antagonist, BQ-123 (PubMed:11880368, PubMed:12414644). Does not appear to actively transport drugs outside the cell. Confers low levels of cellular resistance to etoposide, teniposide, anthracyclines and cisplatin (PubMed:12414644). {ECO:0000269|PubMed:11880368, ECO:0000269|PubMed:12414644}.; FUNCTION: [Isoform 1]: Mediates the release of nucleoside triphosphates, predominantly ATP, into the circulation, where it is rapidly converted into AMP and the mineralization inhibitor inorganic pyrophosphate (PPi) by the ecto-enzyme ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1), therefore playing a role in PPi homeostasis. {ECO:0000269|PubMed:24277820, ECO:0000269|PubMed:24969777}.; FUNCTION: [Isoform 2]: Inhibits TNF-alpha-mediated apoptosis through blocking one or more caspases. {ECO:0000269|PubMed:23912081}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000219054 | + | 13 | 15 | 221_229 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000219054 | + | 13 | 15 | 359_364 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000396104 | + | 11 | 13 | 221_229 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000396104 | + | 11 | 13 | 359_364 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000573854 | + | 12 | 14 | 221_229 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000573854 | + | 12 | 14 | 359_364 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000575690 | + | 13 | 15 | 221_229 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000575690 | + | 13 | 15 | 359_364 | 503.0 | 578.0 | Nucleotide binding | ATP |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000219054 | + | 13 | 15 | 469_471 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000396104 | + | 11 | 13 | 469_471 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000573854 | + | 12 | 14 | 469_471 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000575690 | + | 13 | 15 | 469_471 | 503.0 | 578.0 | Region | Coenzyme A binding |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1265_1499 | 929.0 | 1504.0 | Domain | ABC transporter 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 947_1228 | 929.0 | 1504.0 | Domain | ABC transmembrane type-1 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1265_1499 | 0 | 100.0 | Domain | ABC transporter 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 311_593 | 0 | 100.0 | Domain | ABC transmembrane type-1 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 629_853 | 0 | 100.0 | Domain | ABC transporter 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 947_1228 | 0 | 100.0 | Domain | ABC transmembrane type-1 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1299_1306 | 929.0 | 1504.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1299_1306 | 0 | 100.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 663_670 | 0 | 100.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1019_1061 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1083_1083 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1105_1175 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1197_1198 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1220_1503 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 961_997 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1019_1061 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1083_1083 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1105_1175 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1197_1198 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 120_131 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1220_1503 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 150_167 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 189_302 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1_31 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 324_349 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 371_426 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 448_450 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 472_533 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 53_72 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 555_575 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 597_939 | 0 | 100.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 94_98 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 961_997 | 0 | 100.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1062_1082 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D14 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1084_1104 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D15 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1176_1196 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D16 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1199_1219 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D17 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 940_960 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D12 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 998_1018 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D13 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1062_1082 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D14 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1084_1104 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D15 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1176_1196 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D16 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 1199_1219 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D17 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 132_149 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 168_188 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 303_323 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 32_52 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 350_370 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 427_447 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D8 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 451_471 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D9 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 534_554 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D10 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 576_596 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D11 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 73_93 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 940_960 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D12 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 998_1018 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D13 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000575728 | 0 | 2 | 99_119 | 0 | 100.0 | Transmembrane | Helical%3B Name%3D3 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000219054 | + | 13 | 15 | 540_542 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000396104 | + | 11 | 13 | 540_542 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000573854 | + | 12 | 14 | 540_542 | 503.0 | 578.0 | Region | Coenzyme A binding |
Hgene | ACSM2A | chr16:20492243 | chr16:16263710 | ENST00000575690 | + | 13 | 15 | 540_542 | 503.0 | 578.0 | Region | Coenzyme A binding |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 311_593 | 929.0 | 1504.0 | Domain | ABC transmembrane type-1 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 629_853 | 929.0 | 1504.0 | Domain | ABC transporter 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 663_670 | 929.0 | 1504.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 120_131 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 150_167 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 189_302 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 1_31 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 324_349 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 371_426 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 448_450 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 472_533 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 53_72 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 555_575 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 597_939 | 929.0 | 1504.0 | Topological domain | Cytoplasmic | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 94_98 | 929.0 | 1504.0 | Topological domain | Extracellular | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 132_149 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 168_188 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 303_323 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 32_52 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 350_370 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 427_447 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D8 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 451_471 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D9 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 534_554 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D10 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 576_596 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D11 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 73_93 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | ABCC6 | chr16:20492243 | chr16:16263710 | ENST00000205557 | 20 | 31 | 99_119 | 929.0 | 1504.0 | Transmembrane | Helical%3B Name%3D3 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
ACSM2A | |
ABCC6 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ACSM2A-ABCC6 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ACSM2A-ABCC6 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |